Healthcare

Global Hemoglobin A1C Testing Market, Forecast to 2028

Utilizing Data-driven Insights and Innovative Assays for Enhanced Decision-making in Hemoglobin A1C Testing

INDUSTRY
Healthcare

RELEASE DATE
20-Oct-2023
REGION
North America
DELIVERABLE TYPE
Market Research

RESEARCH CODE
K960-01-00-00-00
SKU
HC_2023_255
Yes
SHARE

Global Hemoglobin A1C Testing Market, Forecast to 2028
Published on: 20-Oct-2023 | SKU: HC_2023_255

Need more details?

$4,950.00

$3,712.50 save 25 %

DownloadLink
Need more details?

The global hemoglobin A1C (HbA1c) testing market will witness significant growth driven by technological advances and the increasing adoption of point-of-care testing (POCT). Real-time glucose monitoring and conventional HbA1c testing have been integrated, revolutionizing patient care by offering better treatment choices and better results. By streamlining data collection, this integration improves operational effectiveness in healthcare settings. POCT options play a significant role as well, offering on-the-spot HbA1c testing for rapid outcomes and prompt action, further improving patient satisfaction and saving valuable assets.

Collaborations between medical device manufacturers, healthcare IT businesses, and pharmaceutical companies determine the competitive landscape in the HbA1c testing market. By promoting industrial convergence and the development of integrated solutions, these partnerships position companies as market leaders with cutting-edge products. Companies that capitalize on this trend early on have an advantage over competitors and create new business prospects by addressing the rising need for all-inclusive diabetes management products.

Why is it Increasingly Difficult to Grow?

The Strategic Imperative 8™

The Impact of the Top 3 Strategic Imperatives on the HbA1c Testing Industry

Growth Opportunities Fuel the Growth Pipeline Engine™

Scope of the Study

Segmentation by Setting

Segmentation by End Users

Segmentation by Technology

Key Competitors

Global Diabetes Highlights, 2021

Number of People with Diabetes, 2021–2045

Top 10 Countries or Territories for Number of Adults

Growth Metrics

Growth Drivers

Growth Restraints

Forecast Assumptions

Revenue Forecast

Revenue Forecast Analysis

Revenue Forecast by Region

Revenue Forecast Analysis by Region

Revenue Forecast Analysis by Region (continued)

Revenue Forecast Analysis by Region (continued)

Revenue Forecast Analysis by Region (continued)

Revenue Forecast Analysis by Region (continued)

Revenue Forecast By Setting

Revenue Forecast Analysis by Setting

Revenue Forecast Analysis by Setting (continued)

Revenue Forecast by End Users

Revenue Forecast Analysis by End Users

Revenue Forecast by Technology

Revenue Forecast Analysis by Technology

Revenue Forecast Analysis by Technology (continued)

Pricing Trends and Analysis

Pricing Trends and Analysis (continued)

Key Pricing Strategies Adopted by Players

Future Aspect of Pricing

Global HbA1c Testing Market—Notable Activities

Global HbA1c Testing Market—Notable Activities (continued)

Global HbA1c Testing Reimbursement Pathways

Competitive Environment

Companies to Watch—Abbott Laboratories

Companies to Watch—Roche Diagnostics

Companies to Watch—Siemens Healthineers

Companies to Watch—Beckman Coulter

Companies to Watch—Tosoh Corporation

Companies to Watch—Bio-Rad Laboratories

Companies to Watch—EKF Diagnostics

Companies to Watch—Erba Diagnostics, Inc.

Companies to Watch—Diazyme Laboratories

Companies to Watch—PTS Diagnostics

Companies to Watch—Trinity Biotech

Competitive Mapping by HbA1c Offering Parameters

Competitive Mapping by HbA1c Offering Parameters (continued)

Growth Opportunity Summary

Growth Opportunity 1—Tailoring HbA1c Testing Approaches to Individual Patient Characteristics

Growth Opportunity 1—Tailoring HbA1c Testing Approaches to Individual Patient Characteristics (continued)

Growth Opportunity 2—Advancements in POCT for Accurate, Affordable, and User-friendly HbA1c Testing

Growth Opportunity 2—Advancements in POCT for Accurate, Affordable, and User-friendly HbA1c Testing (continued)

Growth Opportunity 3—Capturing Opportunities in Growing Diabetes Care Markets

Growth Opportunity 3—Capturing Opportunities in Growing Diabetes Care Markets (continued)

Growth Opportunity 4—Diabetes HbA1c Screening for Better Care and Management

Growth Opportunity 4—Diabetes HbA1c Screening for Better Care and Management (continued)

Your Next Steps

Why Frost, Why Now?

List of Exhibits

Legal Disclaimer


Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Healthcare research

19 Nov 2026   |   Global   |   Technology Research

Programmable Vaccines: AI-Designed Antigens and Next-Generation Rapid Platforms

Traditional vaccine development is an empirical, time-consuming process that often leads to a high failure rate. With the proven clinical success of RNA vaccines, there has been a focus on accelerating the development of vaccines to address the growing incidence of infectious diseases and emerging p...

17 Nov 2026   |   Global   |   Frost Radar

Frost Radar™: Quantum-Grade Sensor Technology Ecosystem for Healthcare Applications, 2026

Quantum-grade sensors are advancing healthcare by leveraging quantum phenomena to enable highly sensitive, precise, and non-invasive measurements of biological signals and physiological parameters. These innovations enhance diagnostic accuracy, disease monitoring, brain activity measurement, and ear...

16 Nov 2026   |   North America   |   Frost Radar

Frost Radar™: Healthcare Data Interoperability Platforms and Integration Engines in North America, 2026

This Frost Radar™ analyzes the healthcare data platform and integration engine vendors that enable healthcare organization to improve the exchange, utilization, contextualization, and management of clinical, operational, financial, and administrative data. Data issues, AI adoption, and solution gove...

03 Nov 2026   |   North America   |   Market Research

Enterprise Imaging Market, United States, 2025–2030

Enterprise imaging is no longer a technology upgrade. It is becoming the operating model for imaging across the provider organization, and the next investment cycle will decide which vendors lead it. This study gives vendors, ecosystem partners, and provider leaders a 360-degree view of that shift, ...

02 Nov 2026   |   Global   |   Market Research

Continuous Glucose Monitoring Market, Global, 2026

The global continuous glucose monitoring (CGM) market is undergoing a fundamental transformation as the technology evolves from a prescription-led glucose monitoring device into an AI-connected metabolic intelligence ecosystem. Market expansion is increasingly driven by the emergence of over-the-cou...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.